Biologics Anchoring Study
Completed · Not applicable
Conditions studied: Moderate-to-severe Psoriasis
In brief
Biologics are used to treat conditions such as moderate-to-severe psoriasis, a chronic condition that impairs quality of life as much or more than other major medical conditions. Biopharmaceuticals are medications which are are isolated from biological sources including microorganisms, animals or humans. These medications generally function to decrease inflammation or disrupt the inflammatory cycle. Patients are often apprehensive about choosing a biologic medication over other options due to anxiety regarding the need for regular injections, leaving the patient undertreated and continuing to suffer with psoriasis. Reducing fears of injections may improve adherence to treatment and may improve treatment outcomes. Fear of injection is inherently subjective and may be easily modified. Anchoring is the tendency for humans to rely on a specific value when making decisions and to make judgments relative to that value. Patients who have never taken an injection will subjectively view the idea of taking an injection relative to the "not taking any injection" baseline. This comparison is scary and represents a considerable hurdle to taking a new injectable medication that may be otherwise optimal for their treatment. Resetting the anchor may be all that is needed to help patients overcome fear of injection. The objective is to assess whether patients offered a once monthly injectable biologic would be more likely to accept that biologic medication if they are first counseled about a daily injection.
Key facts
- Study ID
- NCT03026153
- Run by
- Wake Forest University Health Sciences
- People needed
- 100
- Starts
- 2016-10-01
- Expected to finish
- 2017-07-01
- Last updated by the study team
- 2018-06-11
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- moderate-to-severe psoriasis
- not currently managed with biologic or other injectable medication
You may not qualify if…
- Individuals younger than 18 (line of questioning necessary for the study may be beyond understanding in this age group)
- Currently managed with biologic medication or other injectable medication
Where it is running
- Dept of Dermatology, WFUHS — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.